The U.S. Food and Drug Administration has given Medtronic (NYSE:MDT) the go-ahead on a clinical trial to test its next generation of MRI pacemaker technology, the Minnesota company announced Monday.
CHICAGO — One person’s used pacemaker is another person’s treasure. A program to refurbish used pacemakers could expand access to the lifesaving devices. In a clinical trial of nearly 300 people, ...
Munich, Germany - In a recent study evaluating the safety of airport metal detectors on implantable cardioverter devices (ICDs) and pacemakers, German investigators conclude that airport security ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results